Creatio is the leading Academic Center for the Production and Validation of Advanced Therapies of State associated with the University of Barcelona and technological developer with TECNIO accreditation, that promotes innovation and translation.
Creatio perform all the activities and processes following high quality standards under compliance of ISO 9001:2015, GLP (Good Laboratory Practices) and GMP (Good Manufacturing Practices).
With long-standing experience, Creatio provides support and solutions that cover all the development process of a healthcare product to increase the efficiency of the healthcare system and improve the quality of life of society.
With a forceful focus on translation, we use our expertise in cell and molecular biology; in preclinical studies and clinical production; and in regulatory aspects to develop effective cutting-edge drugs and treatments for patients. Our experience in cell, gene therapy and tissue engineering aims to bridge the gap between research and clinical applications.
15 April, 2024
Dr Josep M Canals, professor at the UB and Director of Creatio, presents Creatio, validation and production center of advanced therapies at UB, in the Coffee Connection event organized by the Barcelona Science Park…
28 March, 2024
Dr Jordi Abante, with 10 years of experience in the field of computational biology and currently a postdoctoral researcher at Creatio, Production and Validation center of Advanced Therapies at the University of…
21 March, 2024
On Thursday, March 21 and Friday, March 22, 2024, the 16th edition of UniStem Day returns with the topoc “the never-ending journey of stem cell research” At the national level, this day is part of the Spanish…
8 August, 2023
The pioneering research carried out by the Stem Cells and Regenerative Medicine research group of the Basic and Translational Research Area of Creatio - University of Barcelona, demonstrates the crucial role played by…
Creatio has been the first center to produce lentiviruses for CAR-T (Chimeric Antigen Receptor-T) cells treatment in clinical trials in Spain This new breed of treatment is currently revolutionizing the therapeutic…
CHDI Foundation is a privately-funded, not-for-profit biomedical research organization devoted to a single disease – Huntington’s disease Its mission is to develop drugs that will slow the progression of…
The first accreditation from the Spanish Agency of Medicine and Sanitary Products (AEMPS) to Creatio Production and Validation Center of Advanced Therapies in the University of Barcelona: permission is granted to…
